Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1892 1
1929 1
1930 1
1934 6
1935 2
1936 6
1938 1
1946 2
1947 1
1948 6
1949 1
1950 4
1951 3
1952 2
1953 3
1954 5
1955 4
1956 4
1957 9
1958 9
1959 11
1960 5
1961 7
1962 17
1963 21
1964 27
1965 44
1966 66
1967 17
1968 74
1969 100
1970 88
1971 76
1972 91
1973 93
1974 121
1975 144
1976 150
1977 158
1978 141
1979 238
1980 241
1981 272
1982 297
1983 385
1984 464
1985 461
1986 564
1987 735
1988 837
1989 884
1990 957
1991 875
1992 976
1993 1134
1994 1306
1995 1345
1996 1536
1997 1755
1998 1760
1999 2056
2000 2465
2001 2769
2002 3136
2003 3688
2004 4391
2005 5232
2006 5848
2007 6368
2008 7210
2009 8037
2010 9184
2011 10383
2012 11736
2013 13352
2014 15351
2015 17379
2016 18606
2017 19755
2018 22561
2019 25954
2020 30490
2021 34376
2022 15790
2023 2
Text availability
Article attribute
Article type
Publication date

Search Results

282,334 results
Results by year
Filters applied: . Clear all The following term was not found in PubMed: Yuh-Jong
Page 1
Collaboration.
Hu C. Hu C. Anal Chem. 2021 Nov 9;93(44):14577. doi: 10.1021/acs.analchem.1c04544. Anal Chem. 2021. PMID: 34749502 No abstract available.
Abatacept in interstitial lung disease associated with rheumatoid arthritis: national multicenter study of 263 patients.
Fernández-Díaz C, Castañeda S, Melero-González RB, Ortiz-Sanjuán F, Juan-Mas A, Carrasco-Cubero C, Casafont-Solé I, Olivé A, Rodríguez-Muguruza S, Almodóvar-González R, Castellanos-Moreira R, Rodríguez-García SC, Aguilera-Cros C, Villa I, Ordóñez-Palau S, Raya-Alvarez E, Morales-Garrido P, Ojeda-García C, Moreno-Ramos MJ, Bonilla Hernán MG, Hernández Rodríguez I, López-Corbeto M, Andreu JL, Jiménez de Aberásturi JRD, Ruibal-Escribano A, Expósito-Molinero R, Pérez-Sandoval T, López-Robles AM, Carreira-Delgado P, Mena-Vázquez N, Urruticoechea-Arana A, Peralta-Ginés C, Arboleya-Rodríguez L, Narváez García FJ, Palma-Sánchez D, Cervantes Pérez EC, Maiz-Alonso O, Alvarez-Rivas MN, Fernández-Melón J, Vela Casasempere P, Cabezas-Rodríguez I, Castellvi-Barranco I, González-Montagut C, Blanco-Madrigal J, Del Val-Del Amo N, Fito MC, Rodríguez-Gómez M, Salgado-Pérez E, García-Magallón B, Hidalgo-Calleja C, López-Sánchez R, Fernández-Aguado S, Fernández-López JC, Castro-Oreiro S, Serrano-García I, García-Valle A, Romero-Yuste S, Expósito-Pérez L, Pérez-Albadalejo L, García-Aparicio A, Quillis-Marti N, Bernal-Vidal JA, Loricera-García J, Hernández JL, González-Gay MA, Blanco R. Fernández-Díaz C, et al. Rheumatology (Oxford). 2020 Dec 1;59(12):3906-3916. doi: 10.1093/rheumatology/keaa621. Rheumatology (Oxford). 2020. PMID: 33068439
Hu Replies.
Hu SX. Hu SX. Phys Rev Lett. 2018 Mar 16;120(11):119502. doi: 10.1103/PhysRevLett.120.119502. Phys Rev Lett. 2018. PMID: 29601730 No abstract available.
HU-AB simulacrum: Fusion of HU-B and HU-A into HU-B-A, a functional analog of the Escherichia coli HU-AB heterodimer.
Arora K, Thakur B, Gupta A, Guptasarma P. Arora K, et al. Biochem Biophys Res Commun. 2021 Jun 30;560:27-31. doi: 10.1016/j.bbrc.2021.04.107. Epub 2021 May 5. Biochem Biophys Res Commun. 2021. PMID: 33964504
The analog was constructed through genetic fusion of the HU-B and HU-A chains into a single polypeptide (HU-B-A) with a glycine/serine-rich linker of 11 amino acids separating HU-B from HU-A, and a histidine tag at the N-terminus of HU-B. …
The analog was constructed through genetic fusion of the HU-B and HU-A chains into a single polypeptide (HU-B-A) with a …
Cannabidiol oxidation product HU-331 is a potential anticancer cannabinoid-quinone: a narrative review.
Trac J, Keck JM, Deweese JE. Trac J, et al. J Cannabis Res. 2021 Apr 23;3(1):11. doi: 10.1186/s42238-021-00067-z. J Cannabis Res. 2021. PMID: 33892826 Free PMC article. Review.
For example, HU-331 displays inhibitory activity against human topoisomerase IIalpha, a known anticancer drug target. Further, in multiple cell model systems, the IC(50) value for HU-331 was less than 10 muM. In addition, mouse model systems demonstrate the ability …
For example, HU-331 displays inhibitory activity against human topoisomerase IIalpha, a known anticancer drug target. Further, in mul …
Interaction of the Escherichia coli HU Protein with Various Topological Forms of DNA.
Huang L, Zhang Z, McMacken R. Huang L, et al. Biomolecules. 2021 Nov 19;11(11):1724. doi: 10.3390/biom11111724. Biomolecules. 2021. PMID: 34827722 Free PMC article.
Using radiolabeled HU, we examine the effects of DNA supercoiling on HU-DNA interactions. ...This binding preference, however, becomes negligible at HU/DNA mass ratios higher than 1:2. At saturation, HU binds both negatively supercoiled and relaxed DNA …
Using radiolabeled HU, we examine the effects of DNA supercoiling on HU-DNA interactions. ...This binding preference, however, …
Baby's Rainbow.
Hu JC. Hu JC. Sci Am. 2017 Aug 15;317(3):16. doi: 10.1038/scientificamerican0917-16a. Sci Am. 2017. PMID: 28813395 No abstract available.
HTLV-1 uveitis.
Kamoi K, Mochizuki M. Kamoi K, et al. Front Microbiol. 2012 Jul 24;3:270. doi: 10.3389/fmicb.2012.00270. eCollection 2012. Front Microbiol. 2012. PMID: 22837757 Free PMC article.
HU occurs with a sudden onset of floaters and foggy vision, and is classified as an intermediate uveitis. ...Further investigation is needed to establish a specific treatment for HU....
HU occurs with a sudden onset of floaters and foggy vision, and is classified as an intermediate uveitis. ...Further investigation is
Therapeutic Dose of Hydroxyurea-Induced Synaptic Abnormalities on the Mouse Spermatocyte.
Fan X, Zhu Y, Wang N, Zhang B, Zhang C, Wang Y. Fan X, et al. Front Physiol. 2021 Jul 9;12:666339. doi: 10.3389/fphys.2021.666339. eCollection 2021. Front Physiol. 2021. PMID: 34305635 Free PMC article.
Hydroxyurea (HU) is a widely used pharmacological therapy for sickle cell disease (SCD). ...Therefore, this study provides new evidence of the mechanisms underlying HU reproductive toxicity....
Hydroxyurea (HU) is a widely used pharmacological therapy for sickle cell disease (SCD). ...Therefore, this study provides new eviden …
Bilingual Boost.
Hu JC. Hu JC. Sci Am. 2018 May 15;318(6):22. doi: 10.1038/scientificamerican0618-22a. Sci Am. 2018. PMID: 29949548 No abstract available.
282,334 results
You have reached the last available page of results. Please see the User Guide for more information.